Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biosynthesis of valanimycin.

M Yamato, T Takeuchi, H Umezawa

    The Journal of Antibiotics
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    5-HT3 receptor antagonists. 1. New quinoline derivatives.

    Journal of medicinal chemistry·1992
    Same author

    New bronchodilators. II. 3H-imidazo[4,5-c]quinolin-4(5H)-ones.

    Chemical & pharmaceutical bulletin·1992
    Same author

    Site of attachment of mercuribenzoate in crystals of an actin:DNase I complex.

    Journal of biochemistry·1992
    Same author

    Further studies on aspartate aminotransferase of thermophilic methanogens by analysis of general properties, bound cofactors, and subunit structures.

    Journal of biochemistry·1992
    Same author

    Elevated expression of the ornithine decarboxylase gene in human esophageal cancer.

    Cancer research·1992
    Same author

    Experimental chemotherapy for xenograft cell lines of human bile duct and gall bladder cancers in nude mice.

    Journal of surgical oncology·1992

    Valanimycin biosynthesis primarily uses valine for its isobutyl group and alanine for the acrylic moiety. Alanine can also convert to valine, contributing to the isobutyl group, with biosynthesis inhibited by anaerobic conditions.

    Area of Science:

    • Biochemistry
    • Organic Chemistry
    • Microbial Metabolism

    Background:

    • Valanimycin is an antibiotic with a complex structure.
    • Understanding its biosynthesis is crucial for potential applications and modifications.
    • Amino acid precursors play a key role in antibiotic synthesis.

    Purpose of the Study:

    • To elucidate the specific roles of valine and alanine in valanimycin biosynthesis.
    • To investigate the metabolic pathways involved in incorporating these amino acids.
    • To identify factors that influence the rate of valanimycin production.

    Main Methods:

    • Tracing the incorporation of isotopically labeled valine and alanine into valanimycin.
    • Analyzing the structural moieties of valanimycin derived from these amino acids.

    Related Experiment Videos

  • Investigating the effect of environmental conditions (e.g., oxygen levels, reducing agents) on biosynthesis.

    • Main Results:

    • Valine is predominantly incorporated into the isobutyl moiety of valanimycin.
    • Alanine serves as the precursor for the alpha-substituted acrylic moiety.
    • A portion of alanine is metabolized into valine, subsequently contributing to the isobutyl moiety.
    • Anaerobic conditions and certain reducing agents significantly inhibit valanimycin biosynthesis.

    Conclusions:

    • The biosynthesis of valanimycin involves distinct incorporation pathways for valine and alanine.
    • Metabolic interconversion between alanine and valine occurs during biosynthesis.
    • Environmental factors critically regulate the efficiency of valanimycin production.